Alterity Therapeutics Ltd.
(NASDAQ : PRAN)

( )
PRAN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
VTLVital Therapies, Inc.
1.50%13.513.3%$792.68m
AMGNAmgen Inc.
0.97%206.001.3%$773.44m
GILDGilead Sciences, Inc.
1.54%64.110.9%$388.34m
CELGCelgene Corporation
0.51%95.221.3%$348.72m
BIIBBiogen Inc.
1.74%235.721.3%$309.32m
ILMNIllumina, Inc.
0.87%288.653.5%$303.84m
VRTXVertex Pharmaceuticals Incorporated
1.16%187.091.9%$267.03m
ALXNAlexion Pharmaceuticals, Inc.
1.65%112.682.0%$250.97m
EXASExact Sciences Corporation
-1.39%118.1624.1%$248.01m
REGNRegeneron Pharmaceuticals, Inc.
0.52%298.382.6%$217.05m
AAgilent Technologies, Inc.
0.96%71.761.6%$206.55m
SRPTSarepta Therapeutics, Inc.
-3.71%120.3114.7%$153.85m
INCYIncyte Corporation
1.68%84.522.5%$100.26m
BMRNBioMarin Pharmaceutical Inc.
1.19%77.414.3%$94.71m
GHDXGenomic Health, Inc.
-0.56%74.221.8%$90.42m

Company Profile

Alterity Therapeutics Ltd. engages in the development of therapy treatment for neurodegenerative disease. It includes research and development of treatments for Alzheimer's and Huntington's disease. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Parkville, Australia.